SEC Form 4 · accession 0001209191-18-058344

Regulus Therapeutics Inc. · RGLS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Nov 12, 2018

Accepted (ET)

Nov 13, 2018 · 5:33 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001505512

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Nov 12, 2018	A	23,258	—	A	79,672	I	William H. Rastetter TTEE, Marisa Rastetter TTEE 9-2-2010 FBO Rastetter Family Trust

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	D/I
Stock Option (Right to Buy)^F2,F4,F3	$92.04	Nov 12, 2018	D	2,500	D	—	Mar 31, 2023	Common Stock	2,500	I
Stock Option (Right to Buy)^F2,F4,F3	$111.84	Nov 12, 2018	D	1,458	D	—	Jun 9, 2023	Common Stock	1,458	I
Stock Option (Right to Buy)^F2,F4,F3	$74.64	Nov 12, 2018	D	1,458	D	—	May 21, 2024	Common Stock	1,458	I
Stock Option (Right to Buy)^F2,F4,F3	$120.24	Nov 12, 2018	D	1,458	D	—	Jun 8, 2025	Common Stock	1,458	I
Stock Option (Right to Buy)^F2,F4,F3	$74.40	Nov 12, 2018	D	3,051	D	—	May 31, 2026	Common Stock	3,051	I
Stock Option (Right to Buy)^F2,F4,F3	$17.40	Nov 12, 2018	D	2,500	D	—	May 30, 2027	Common Stock	2,500	I
Stock Option (Right to Buy)^F2,F4,F5	$8.52	Nov 12, 2018	D	6,250	D	—	May 16, 2028	Common Stock	6,250	I
Stock Option (Right to Buy)^F2,F4,F6	$8.76	Nov 12, 2018	D	4,583	D	—	May 31, 2028	Common Stock	4,583	I

F1On November 12, 2018, the issuer canceled, pursuant to the issuer's option exchange program, the options listed below in Table II. In exchange for the options cancelled, the reporting person received Restricted Stock Units (RSUs) as reported in this Table I. The RSUs vest ratably on a quarterly basis, such that the the RSUs are fully vested one year after the date of grant, subject to the reporting person's continuous service to Regulus through each vesting date.
F2Share numbers and exercise price reflect the 12-to-1 reverse stock split of the Issuer's common stock effective October 3, 2018.
F3The shares subject to the cancelled option were fully vested.
F4On November 12, 2018, the issuer cancelled, pursuant to the issuer's option exchange program, the listed option. In exchange for the options cancelled, the reporting person received the Restricted Stock Units reported above in Table I.
F5The cancelled option provided for vesting in 12 equal monthly installments commencing on the date of grant.
F6The cancelled option vested in twelve equally monthly installments, such that the option would have been fully vested one year from the date of grant, or the date of the Company's next annual shareholder meeting, whichever occured first.